27.01.2016 • NewsDede WillamsCovestroBayer

Covestro Invests €20 Million in PC Film Expansion

Covestro, the former Bayer MaterialScience, is investing around €20 million in one of its downstream operations, expanding capacity for polycarbonate film at Dormagen, Germany.

The company’s plans encompass a new coextrusion plant for high-end multilayer flat films, including associated infrastructure and logistics. The plant due on stream in 2017 will manufacture products for security cards, automotive interiors, medical devices and displays.

“With the new plant, we are orienting ourselves more than ever on market trends and the rising demand for high-quality flat films,” said Nina Schmarander, global head of Specialty Films. For Covestro, the new facility represents a “further developmental step for multilayer film structures, such as those used for counterfeit-proof identity cards,” she added.

In other news, Covestro has announced the appointment of Michelle Jou as head of the company’s Polycarbonates business unit, which is based in Shanghai, China. Jou succeeds Markus Steilemann, who has moved to the Polyurethanes unit and also has become a member of the company’s managing board, overseeing Innovation.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.